Tus kws kho mob
QP64-19 Platinum Blue Choice Member Copays
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 26, 2019
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2551 - 2560 ntawm 4179
Tus kws kho mob
QP65-19 Denial, Termination, Reduction (DTR) Notices not Generated
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 26, 2019
Tus kws kho mob
QP62-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Interleukin 5 (IL-5) Inhibitors
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 26, 2019
Tus kws kho mob
QP60-19 2019 Blue Cross Basic Seminars
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 26, 2019
Tus kws kho mob
QP61-19 Availity Portal Authorization Frequently Asked Questions
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 26, 2019
Tus kws kho mob
QP63-19 When the Authorization Tool is Utilized on the Availity Portal
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 26, 2019
Tus kws kho mob
QP58-19 Pharmacy Benefit Exclusion for Zolgensma (onasemnogene abeparvovec-xioi) Injection
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 12, 2019
Tus kws kho mob
QP56-19 Pharmacy Benefit Update – New Drug-Related Step Therapy Criteria: Topical Corticosteroids
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 12, 2019
Tus kws kho mob
QP48-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Somatostatin Analogs
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 12, 2019
Tus kws kho mob
QP47-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Hereditary transthyretin-mediated (hATTR) Amyloidosis Neuropathy
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 12, 2019